Vivos Inc. (RDGL) intrinsic value & 10-year financials

Vivos Inc. (RDGL) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 26.7% a year to $68.4K, with an average return on invested capital of -446.2%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$0.05
Market cap
$22.0M
Revenue (FY2025)
$68.4K
Revenue growth (10-yr CAGR)
26.7%
ROIC (10-yr avg)
-446.2%
Free cash flow (FY2025)
-$2.2M

RDGL 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $68.4K -$3.1M -$0.01 -$2.2M -4628.7% -1603.9%
FY2024 $28.0K -$2.9M -$0.01 — -9303.0% —
FY2023 $19.5K -$2.9M -$0.01 — -14323.8% —
FY2022 $36.5K -$2.5M -$0.01 — -6898.1% —
FY2021 $14.9K -$2.5M — — -16805.3% —
FY2020 $7.0K -$957.0K — — -9607.4% —
FY2019 $9.5K -$1.6M — — -13999.8% 115.0%
FY2018 — -$7.7M — — — —
FY2017 $4.1K -$6.4M — — -64551.4% 150.3%
FY2016 $8.1K -$9.9M — — -54717.2% —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

VIVOS INC is a consistent compounder, expanding top-line revenue at 26.7% annually over the past decade.

VIVOS INC has earned high returns on invested capital, averaging 33.5% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.

VIVOS INC capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, VIVOS INC is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-0.33 per share.

RDGL stock: frequently asked questions

What is the intrinsic value of Vivos Inc. (RDGL) stock?

Graham's formula only works with positive earnings. Vivos Inc. reported diluted EPS of -$0.01 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

How fast has Vivos Inc. grown?

Revenue went from $8.1K in fiscal 2016 to $68.4K in fiscal 2025, a compound annual growth rate of 26.7%. Net income was -$3.1M in fiscal 2025.

Does Vivos Inc. generate free cash flow?

Vivos Inc. generated -$2.2M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 1 reported years.

What is RDGL's return on invested capital?

Average ROIC over the last 10 fiscal years was -446.2%, and average return on equity was -33.5%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this RDGL data come from?

From Vivos Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Aug 12, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar surgical & medical instruments & apparatus stocks